BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37314336)

  • 1. No Association between the Plasmodium vivax
    Rumaseb A; Moraes Barros RR; Sá JM; Juliano JJ; William T; Braima KA; Barber BE; Anstey NM; Price RN; Grigg MJ; Marfurt J; Auburn S
    Antimicrob Agents Chemother; 2023 Jul; 67(7):e0161022. PubMed ID: 37314336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug resistance genes: pvcrt-o and pvmdr-1 polymorphism in patients from malaria endemic South Western Coastal Region of India.
    Joy S; Mukhi B; Ghosh SK; Achur RN; Gowda DC; Surolia N
    Malar J; 2018 Jan; 17(1):40. PubMed ID: 29351800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmodium vivax resistance to chloroquine in Madagascar: clinical efficacy and polymorphisms in pvmdr1 and pvcrt-o genes.
    Barnadas C; Ratsimbasoa A; Tichit M; Bouchier C; Jahevitra M; Picot S; Ménard D
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4233-40. PubMed ID: 18809933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in chloroquine resistance-associated genes in Plasmodium vivax in Ethiopia.
    Golassa L; Erko B; Baliraine FN; Aseffa A; Swedberg G
    Malar J; 2015 Apr; 14():164. PubMed ID: 25889237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of Mutations Associated with Antifolate and Chloroquine Resistance among Imported
    Bansal D; Acharya A; Bharti PK; Abdelraheem MH; Elmalik A; Abosalah S; Khan FY; ElKhalifa M; Kaur H; Mohapatra PK; Sehgal R; Idris MA; Mahanta J; Singh N; Babiker HA; Sultan AA
    Am J Trop Med Hyg; 2017 Dec; 97(6):1797-1803. PubMed ID: 29016333
    [No Abstract]   [Full Text] [Related]  

  • 6. Analysis of Plasmodium vivax Chloroquine Resistance Transporter Mutant Isoforms.
    Hassett MR; Riegel BE; Callaghan PS; Roepe PD
    Biochemistry; 2017 Oct; 56(41):5615-5622. PubMed ID: 28898049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal ex vivo and molecular trends of chloroquine and piperaquine activity against Plasmodium falciparum and P. vivax before and after introduction of artemisinin-based combination therapy in Papua, Indonesia.
    Marfurt J; Wirjanata G; Prayoga P; Chalfein F; Leonardo L; Sebayang BF; Apriyanti D; Sihombing MAEM; Trianty L; Suwanarusk R; Brockman A; Piera KA; Luo I; Rumaseb A; MacHunter B; Auburn S; Anstey NM; Kenangalem E; Noviyanti R; Russell B; Poespoprodjo JR; Price RN
    Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():46-56. PubMed ID: 34193398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Proportion of Genome-Wide Homology and Increased Pretreatment
    Rovira-Vallbona E; Van Hong N; Kattenberg JH; Huan RM; Binh NTH; Ngọc NTH; Guetens P; Hieu NL; Hien NTT; Sang VT; Long ND; Sauve E; Duong TT; Xa NX; Erhart A; Rosanas-Urgell A
    Antimicrob Agents Chemother; 2021 Jul; 65(8):e0009521. PubMed ID: 34031050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Plasmodium vivax crt-o Is Related to Parasite Stage but Not Ex Vivo Chloroquine Susceptibility.
    Pava Z; Handayuni I; Wirjanata G; To S; Trianty L; Noviyanti R; Poespoprodjo JR; Auburn S; Price RN; Marfurt J
    Antimicrob Agents Chemother; 2016 Jan; 60(1):361-7. PubMed ID: 26525783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chloroquine resistance is associated to multi-copy pvcrt-o gene in Plasmodium vivax malaria in the Brazilian Amazon.
    Silva SR; Almeida ACG; da Silva GAV; Ramasawmy R; Lopes SCP; Siqueira AM; Costa GL; Sousa TN; Vieira JLF; Lacerda MVG; Monteiro WM; de Melo GC
    Malar J; 2018 Jul; 17(1):267. PubMed ID: 30012145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the in vitro sensitivity with associated drug resistance polymorphisms in Plasmodium vivax clinical isolates from Delhi, India.
    Matlani M; Kumar A; Singh V
    Exp Parasitol; 2021 Jan; 220():108047. PubMed ID: 33221328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmodium vivax chloroquine resistance links to pvcrt transcription in a genetic cross.
    Sá JM; Kaslow SR; Moraes Barros RR; Brazeau NF; Parobek CM; Tao D; Salzman RE; Gibson TJ; Velmurugan S; Krause MA; Melendez-Muniz V; Kite WA; Han PK; Eastman RT; Kim A; Kessler EG; Abebe Y; James ER; Chakravarty S; Orr-Gonzalez S; Lambert LE; Engels T; Thomas ML; Fasinu PS; Serre D; Gwadz RW; Walker L; DeConti DK; Mu J; Bailey JA; Sim BKL; Hoffman SL; Fay MP; Dinglasan RR; Juliano JJ; Wellems TE
    Nat Commun; 2019 Sep; 10(1):4300. PubMed ID: 31541097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular surveillance of chloroquine resistance in Plasmodium vivax isolates from malaria cases in Yunnan Province of China using pvcrt-o gene polymorphisms.
    Ding H; Dong Y; Deng Y; Xu Y; Liu Y; Wu J; Chen M; Zhang C; Liu L; Lin Y
    Malar J; 2023 Nov; 22(1):338. PubMed ID: 37940956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmodium vivax mdr1 genotypes in isolates from successfully cured patients living in endemic and non-endemic Brazilian areas.
    Gomes LR; Almeida-de-Oliveira NK; de Lavigne AR; de Lima SR; de Pina-Costa A; Brasil P; Daniel-Ribeiro CT; Ménard D; Ferreira-da-Cruz Mde F
    Malar J; 2016 Feb; 15():96. PubMed ID: 26887935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular epidemiology of potential candidate markers for chloroquine resistance in imported Plasmodium vivax malaria cases in Iran.
    Pirahmadi S; Afzali S; Mehrizi AA; Raz A; Raeisi A
    Malar J; 2023 Apr; 22(1):118. PubMed ID: 37038137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An unlabelled probe-based real time PCR and modified semi-nested PCR as molecular tools for analysis of chloroquine resistant Plasmodium vivax isolates from Afghanistan.
    Mosawi SH; Dalimi A; Safi N; Fotouhi-Ardakani R; Ghaffarifar F; Sadraei J
    Malar J; 2020 Jul; 19(1):253. PubMed ID: 32664942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution pattern of amino acid mutations in chloroquine and antifolate drug resistance associated genes in complicated and uncomplicated Plasmodium vivax isolates from Chandigarh, North India.
    Kaur H; Sehgal R; Kumar A; Bharti PK; Bansal D; Mohapatra PK; Mahanta J; Sultan AA
    BMC Infect Dis; 2020 Sep; 20(1):671. PubMed ID: 32933490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chloroquine efficacy studies confirm drug susceptibility of Plasmodium vivax in Chennai, India.
    Shalini S; Chaudhuri S; Sutton PL; Mishra N; Srivastava N; David JK; Ravindran KJ; Carlton JM; Eapen A
    Malar J; 2014 Mar; 13():129. PubMed ID: 24685286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo therapeutic efficacy of chloroquine alone or in combination with primaquine against vivax malaria in Kolkata, West Bengal, India, and polymorphism in pvmdr1 and pvcrt-o genes.
    Ganguly S; Saha P; Guha SK; Das S; Bera DK; Biswas A; Kundu PK; Saha B; Ray K; Maji AK
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1246-51. PubMed ID: 23262997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance of drug resistance molecular markers in Plasmodium vivax before and after introduction of dihydroartemisinin and piperaquine in Thailand: 2009-2019.
    Suphakhonchuwong N; Rungsihirunrat K; Kuesap J
    Parasitol Res; 2023 Dec; 122(12):2871-2883. PubMed ID: 37725258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.